top of page


Dapagliflozin offers new hope for HFrEF patients
Heart failure (HF) is one of the most common cardiovascular diseases worldwide. The prevalence of heart failure in India is estimated to be about 8-10 million (1). Around 1.8 million hospitalizations occur in India annually due to HF (2). Approximately 50% of these cases can be attributed to HF with reduced ejection fraction (HFrEF), referring to a left ventricular ejection fraction (LVEF) of 40% or less (3). Despite significant advances in treatment, there remains a signific

Ms. Leena Patil
Sep 10, 20253 min read
Â
Â
bottom of page